William F. Glass

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Checkpoint inhibitor-related renal vasculitis and use of rituximab”.

Checkpoint inhibitor-related renal vasculitis and use of rituximab

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000750

N/A

0DataRank · unranked

47 citations

Jamie S. Lin, Maen Abdelrahim, Amanda Tchakarov, William F. Glass, Umut Selamet +4 more

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001287

N/A

0DataRank · unranked

40 citations

Daniel Wang, Omar Mamlouk, William F. Glass, Maen Abdelrahim, Cassian Yee +2 more

Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau

Molecular Psychiatry(2021)10.1038/s41380-020-00992-0

N/A

0DataRank · unranked

55 citations

Colin Carlock, Junbo Shim, Inés Moreno‐González, William F. Glass, April Ross +4 more

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.898811

N/A

0DataRank · unranked

15 citations

Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel +2 more

Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report

Leukemia Research Reports(2023)10.1016/j.lrr.2023.100377

N/A

0DataRank · unranked

3 citations

William F. Glass, Jamie S. Lin, Jan A. Burger, Anna-Ève Turcotte